Genedata AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Genedata AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10886
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genedata AG (Genedata) is a healthcare technology company that transforms data into software solutions. The company delivers enterprise solutions for data analytics that streamline research and development workflows and improve research productivity. Its products include genedata biologics, genedata screener, genedata expressionist, genedata philosopher, genedata analyst and genedata selector. Genedata provides services such as information technology services, data analysis, custom software development, training, and hosting. The company also offers support and training services. It serves pharma, bio-pharma, agribusiness, industrial biotech, food and beverage, and other sectors. The company has presence in Switzerland, Germany, the US and Japan. Genedata is headquartered in Basel, Switzerland.

Genedata AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genedata AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genedata AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genedata AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genedata AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genedata AG, Medical Devices Deals, 2012 to YTD 2018 9
Genedata AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genedata AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Genedata Enters into Integration Agreement with IntelliCyt 11
Ab Sciex, Genedata And Leco Enter Into Agreement For Metabolomics Data Analysis Solution 12
Genedata Enters Into Technology Integration Agreement With Life Technologies 13
Licensing Agreements 14
F-star Biotech Enters into Licensing Agreement with Genedata 14
Genedata Enters into Licensing Agreement with Pfizer 15
Ono Pharma Enters Into Licensing Agreement With Genedata For Genedata Expressionist 16
Takeda Expands Licensing Agreement With Genedata For Genedata Expressionist 17
Roche Extends Licensing Agreement With Genedata 18
Chugai Pharma Extends Licensing Agreement With Genedata For Genedata Expressionist Software 19
Genedata AG – Key Competitors 20
Genedata AG – Key Employees 21
Genedata AG – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Strategy And Business Planning 23
Feb 21, 2017: Genedata Expands Into United Kingdom 23
Financial Announcements 24
Aug 20, 2018: Aptevo Therapeutics deploys Genedata Biologics to streamline Cancer Immunotherapy R&D 24
Government and Public Interest 25
Jul 10, 2018: MyBio Adopts Genedata for Improving Antibiotic Production Processes 25
Product News 26
Jun 06, 2017: Genedata Announces New Solution for Efficient Analysis of High-Throughput Automated Patch Clamp Experiments 26
Feb 02, 2018: Genedata Profiler Powers Major Breakthroughs in Early Prediction of Breast and Ovarian Cancer 27
Jan 31, 2018: Genedata Announces Genedata Screener for Massive Mechanistic Analysis 28
Other Significant Developments 29
Oct 02, 2018: Genedata Bioprocess Offers Out-of-the-Box Integration with ambr Bioreactors 29
Feb 27, 2018: Sanofi Adopts Genedata Selector to Optimize Strain Development 30
Jan 11, 2018: Genedata Announces New Solution for CRISPR Data Management and Analysis 31
Dec 20, 2017: Genedata Profiler Moves to High-Performance Clouds 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Genedata AG, Pharmaceuticals & Healthcare, Key Facts 2
Genedata AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genedata AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genedata AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genedata AG, Deals By Therapy Area, 2012 to YTD 2018 8
Genedata AG, Medical Devices Deals, 2012 to YTD 2018 9
Genedata AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genedata Enters into Integration Agreement with IntelliCyt 11
Ab Sciex, Genedata And Leco Enter Into Agreement For Metabolomics Data Analysis Solution 12
Genedata Enters Into Technology Integration Agreement With Life Technologies 13
F-star Biotech Enters into Licensing Agreement with Genedata 14
Genedata Enters into Licensing Agreement with Pfizer 15
Ono Pharma Enters Into Licensing Agreement With Genedata For Genedata Expressionist 16
Takeda Expands Licensing Agreement With Genedata For Genedata Expressionist 17
Roche Extends Licensing Agreement With Genedata 18
Chugai Pharma Extends Licensing Agreement With Genedata For Genedata Expressionist Software 19
Genedata AG, Key Competitors 20
Genedata AG, Key Employees 21
Genedata AG, Subsidiaries 22

List of Figures
Genedata AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genedata AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genedata AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genedata AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genedata AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genedata AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Genedata AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genedata AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genedata AG, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Genedata AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fresenius Kidney Care-医療機器分野:企業M&A・提携分析
    Summary Fresenius Kidney Care (FMCNA) , formerly Fresenius Medical Care Holdings Inc, a subsidiary of Fresenius Medical Care AG & Co KGaA, is a provider of dialysis services and renal care products. The company’s dialysis products include hemodialysis; dialyzers, haemodialysis machines, FMiS medical …
  • Posco International Corp (047050):企業の財務・戦略的SWOT分析
    Posco International Corp (047050) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Mega Financial Holding Co., Ltd.:戦略・SWOT・企業財務分析
    Mega Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mega Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • iRhythm Technologies Inc (IRTC):医療機器:M&Aディール及び事業提携情報
    Summary iRhythm Technologies Inc (iRhythm) is a digital health care solutions company. It offers non-invasive long-term cardiac rhythm monitors. The company develops the Zio family of products and services to address the clinical needs of patients suffering from arrhythmias. Its product offerings in …
  • Mr. Price Group Ltd.:戦略・SWOT・企業財務分析
    Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Chevron Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Chevron Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Chevron Corp (Chevron) is an integrated oil and gas company. It operates in the oil and gas value chain from exploration and production, storage and pipeline transportation to refining, marketing and di …
  • WEX Inc (WEX):企業の財務・戦略的SWOT分析
    WEX Inc (WEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • CDI Corp.:企業の戦略的SWOT分析
    CDI Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Zecotek Photonics Inc (ZMS):医療機器:M&Aディール及び事業提携情報
    Summary Zecotek Photonics Inc. (Zecotek) is a photonics technology company that focuses on developing advanced materials and integrated optoelectronic devices for optical precision surgery, high resolution medical imaging and biopharmaceutical research. It develops and sells scintillation crystals, …
  • GMR Infrastructure Ltd (GMRINFRA):企業の財務・戦略的SWOT分析
    GMR Infrastructure Ltd (GMRINFRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • GOBARTO S.A.:戦略・SWOT・企業財務分析
    GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report Summary GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Toyota Industries Corp (6201):企業の財務・戦略的SWOT分析
    Toyota Industries Corp (6201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • TransGenic Inc (2342):企業の財務・戦略的SWOT分析
    TransGenic Inc (2342) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Riyad Bank:企業の戦略・SWOT・財務分析
    Riyad Bank - Strategy, SWOT and Corporate Finance Report Summary Riyad Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • ERG Renew SpA:電力:M&Aディール及び事業提携情報
    Summary ERG Renew S.p.A. (ERG Renew), formerly Entad S.p.A., a subsidiary of ERG S.p.A, is a power company that generates electricity from renewable sources. The company generates electricity mainly through wind. ERG Renew and its subsidiaries operate in Italy, France, Bulgaria/Romania, Germany, and …
  • The Second Cup Ltd.:企業の戦略・SWOT・財務分析
    The Second Cup Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Second Cup Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Viatris Inc (VTRS):企業の財務・戦略的SWOT分析
    Viatris Inc (VTRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • BioView Ltd (BIOV):医療機器:M&Aディール及び事業提携情報
    Summary BioView Ltd (BioView) develops, manufactures and markets automated cell imaging and analysis solutions, which incorporate proprietary imaging, analysis and review technology. The technology provides automatic control of fully motorized fluorescent and bright-field microscopes fitted with hig …
  • Chattem Inc:企業の戦略・SWOT・財務情報
    Chattem Inc - Strategy, SWOT and Corporate Finance Report Summary Chattem Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Open Text Corporation (OTEX):企業の財務・戦略的SWOT分析
    Open Text Corporation (OTEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆